These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 2675634)

  • 41. Anti-diabetic effects of vanadium(III, IV, V)-chlorodipicolinate complexes in streptozotocin-induced diabetic rats.
    Li M; Ding W; Smee JJ; Baruah B; Willsky GR; Crans DC
    Biometals; 2009 Dec; 22(6):895-905. PubMed ID: 19404749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Therapeutic potential of vanadium in treating diabetes mellitus].
    Sakurai H
    Clin Calcium; 2005 Jan; 15(1):49-57. PubMed ID: 15632473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of vanadyl sulfate on liver of streptozotocin-induced diabetic rats.
    Koyuturk M; Tunali S; Bolkent S; Yanardag R
    Biol Trace Elem Res; 2005 Jun; 104(3):233-47. PubMed ID: 15930593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic B-cell morphology.
    Mongold JJ; Cros GH; Vian L; Tep A; Ramanadham S; Siou G; Diaz J; McNeill JH; Serrano JJ
    Pharmacol Toxicol; 1990 Sep; 67(3):192-8. PubMed ID: 2255674
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antidiabetic action of vanadyl in rats independent of in vivo insulin-receptor kinase activity.
    Venkatesan N; Avidan A; Davidson MB
    Diabetes; 1991 Apr; 40(4):492-8. PubMed ID: 1849104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of vanadyl sulphate [VOSO4] on biochemical activity and morphology of control and streptozotocin-diabetic rat liver Golgi complexes.
    Dabroś W; Goc A; Turyna B; Kordowiak AM
    Pol J Pathol; 2004; 55(1):25-32. PubMed ID: 15195703
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM; Risovic V; Yuen VG; McNeill JH
    J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decrease of hypothalamic neuropeptide Y gene expression by vanadyl sulfate in streptozotocin-induced diabetic rats.
    Liu IM; Chi TC; Cheng JT
    Horm Metab Res; 2001 Feb; 33(2):96-100. PubMed ID: 11294500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oral vanadate and Tiron in treatment of diabetes mellitus in rats: improvement of glucose homeostasis and negative side-effects.
    Domingo JL; Sanchez DJ; Gomez M; Llobet JM; Corbella J
    Vet Hum Toxicol; 1993 Dec; 35(6):495-500. PubMed ID: 8303815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of oral vanadium on glycaemic and lipid profile in rats.
    Hussain Shah SZ; Naveed AK; Rashid A
    J Pak Med Assoc; 2016 Dec; 66(12):1592-1596. PubMed ID: 28179696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ameliorative effect of vanadium on oxidative stress in stomach tissue of diabetic rats.
    Yilmaz-Ozden T; Kurt-Sirin O; Tunali S; Akev N; Can A; Yanardag R
    Bosn J Basic Med Sci; 2014 May; 14(2):105-9. PubMed ID: 24856383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trophic effects of vanadium on beta-cells of STZ-induced insulin dependent diabetic rats & evidence for long-term relief of diabetes mellitus.
    Dehghani GA; Sotoodeh M; Omrani GR
    Indian J Med Res; 1999 Aug; 110():70-5. PubMed ID: 10573657
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute and chronic response to vanadium following two methods of streptozotocin-diabetes induction.
    Yao J; Battell ML; McNeill JH
    Can J Physiol Pharmacol; 1997 Feb; 75(2):83-90. PubMed ID: 9114928
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
    Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
    J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vanadyl sulfate, taurine, and combined vanadyl sulfate and taurine treatments in diabetic rats: effects on the oxidative and antioxidative systems.
    Tas S; Sarandol E; Ayvalik SZ; Serdar Z; Dirican M
    Arch Med Res; 2007 Apr; 38(3):276-83. PubMed ID: 17350476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effects of vanadyl sulfate on osteopenia in streptozotocin-induced diabetic (STZD) rats. Comparison with those of insulin].
    Arai M
    Nihon Yakurigaku Zasshi; 1992 Nov; 100(5):401-14. PubMed ID: 1464399
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
    Saad SY; Najjar TA
    Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative Assessment of Proliferative Effects of Oral Vanadium on Pancreatic Islet Volumes and Beta Cell Numbers of Diabetic Rats.
    Pirmoradi L; Noorafshan A; Safaee A; Dehghani GA
    Iran Biomed J; 2016; 20(1):18-25. PubMed ID: 26459400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vanadyl sulfate administration protects the streptozotocin-induced oxidative damage to brain tissue in rats.
    Yanardag R; Tunali S
    Mol Cell Biochem; 2006 Jun; 286(1-2):153-9. PubMed ID: 16532257
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vanadium compounds for the treatment of human diabetes mellitus: A scientific curiosity? A review of thirty years of research.
    Domingo JL; Gómez M
    Food Chem Toxicol; 2016 Sep; 95():137-41. PubMed ID: 27417449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.